Skip to content

CNSP

CNS Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$4.34
−4.62%
Ask drillr
  • Oct 2, 2026, 12:02 UTC

    CNS Pharmaceuticals, Inc. appointed Faith Charles, Bettina Cockroft, Michal Fisher, Jeffrey Keyes, Rami Levin, and Amy Mahery as directors effective September 30, 2026.